C. Rankin

Most-cited papers

1. Phase II study of erlotinib in metastatic or unresectable malignant peripheral nerve sheath tumors (MPNST).

   K. Albritton, C. Rankin, Cheryl M. Coffin, N. Ratner +5 more

   2006Journal of Clinical Oncology94 citations

   Semantic Scholar

   Save

2. A Phase II study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants

   Susan M. Chang, J. Kuhn, H. Robins, S. C. Schold +6 more

   2001Cancer70 citations

   Semantic Scholar

   Save

3. Adjuvant therapy of osteosarcoma—A Phase II trial

   M. Zalupski, C. Rankin, J. Ryan, D. Lucas +6 more

   2004Cancer63 citations Open access

   Semantic Scholar

   Save

4. A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: a southwest oncology group study 9617.

   T. Chauncey, C. Rankin, Jeanne E. Anderson, I. Chen +12 more

   2000Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis61 citations

   Semantic Scholar

   Save

5. Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810).

   S. Kalmadi, C. Rankin, M. Kraut, A. Jacobs +5 more

   2008Lung Cancer59 citations Open access

   Semantic Scholar

   Save

6. Multiple Histology Phase II Trials

   M. LeBlanc, C. Rankin, J. Crowley

   2009Clinical Cancer Research31 citations Open access

   Semantic Scholar

   Save

7. A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia.

   Peter Rosen, C. Rankin, D. Head, D. Boldt +5 more

   2000Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis22 citations

   Semantic Scholar

   Save

8. Phase II Trial of Topotecan by Continuous Infusion in Patients with Advanced Soft Tissue Sarcomas, a SWOG Study

   G. Budd, C. Rankin, L. Hutchins, L. Wong +2 more

   2002Investigational new drugs14 citations

   Semantic Scholar

   Save

9. Combined analysis of two phase II trials of imatinib in advanced dermatofibrosarcoma protuberans (DFSP).

   S. Schuetze, P. Rutkowski, M. Van Glabbeke, C. Rankin +6 more

   2016Journal of Clinical Oncology6 citations

   Semantic Scholar

   Save

10. Phase II Trial of Amonafide in Central Nervous System Tumors: A Southwest Oncology Group Study

    Sarah A. Taylor, C. Rankin, J. J. Townsend, J. Craig +4 more

    2002Investigational new drugs6 citations

    Semantic Scholar

    Save

11. Combined analysis of the EORTC and SWOG phase II trials of imatinib in advanced dermatofibrosarcoma protuberans (DFSP)

    S. Schuetze, P. Rutkowski, M. Van Glabbeke, C. Rankin +6 more

    20093 citations

    Semantic Scholar

    Save

12. High‐dose ifosfamide with mesna and granuloctye–colony‐stimulating factor (recombinant human G‐CSF) in patients with unresectable malignant mesothelioma

    S. Talbot, C. Rankin, R. Taub, S. Balcerzak +5 more

    2003Cancer3 citations Open access

    Semantic Scholar

    Save

13. Phase II trial of topotecan by continuous infusion in patients with advanced soft tissue sarcomas, a SWOG study. Southwest Oncology Group.

    G. Budd, C. Rankin, L. Hutchins, L. Wong +2 more

    2002Investigational new drugs2 citations

    Semantic Scholar

    Save

14. Phase II with Multiple Subgroups: Designs Incorporating Disease Subtype or Genetic Heterogeneity

    M. LeBlanc, C. Rankin, J. Crowley

    20120 citations

    Semantic Scholar

    Save

15. SWOG0345: Prospective phase II trial of imatinib in dermatofibrosarcoma protuberans (DFSP)

    S. Schuetze, C. Rankin, B. Rubin, J. Butrynski +1 more

    20080 citations

    Semantic Scholar

    Save